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NHS	Continuing	Healthcare	funding:	anomalous,
irregular,	and	often	baffling
The	boundary	between	health	and	social	care	continues	to	be	a	major	issue,	and	is	especially	stark
around	long-term	care	and	NHS	continuing	healthcare.	Melanie	Henwood	explores	the	issues
raised	by	a	new	report	from	the	National	Audit	Office	and	highlights	the	major	anomalies	around
fully	funded	care	for	some	people,	and	means	tested	social	care	for	others.
The	National	Audit	Office	(NAO)	investigation	into	NHS	continuing	healthcare	funding	published	on
5	July	2017	shines	a	light	on	the	largely	hidden	and	little-known	operation	of	this	area	of	long-term
care.	Amidst	all	the	brouhaha	around	paying	for	care	that	surfaced	during	the	general	election	campaign,	mention
of	continuing	healthcare	was	conspicuously	absent,	yet	the	interface	between	health	and	care	is	never	sharper
than	where	the	two	systems	collide	around	long-term	care.
Continuing	healthcare	(CHC)	refers	to	a	package	of	care	that	is	arranged	and	fully	funded	by	the	NHS	for	people
with	significant,	complex	ongoing	healthcare	needs.	As	the	NAO	remarks,	funding	for	such	care	“is	a	complex
and	highly	sensitive	area,	which	can	affect	some	of	the	most	vulnerable	people	in	society	and	those	that	care	for
them.”
Concerns	about	the	operation,	and	inconsistencies,	of	CHC	have	been	in	evidence	a	considerable	time.	In	a
review	I	was	commissioned	to	undertake	for	the	Department	of	Health	in	2004	I	drew	attention	to	ongoing
problems	that	would	still	exist	if	national	eligibility	criteria	were	to	be	introduced	(as	they	later	were),	not	least
because	of	the	uncertainty	about	the	boundary	between	health	and	social	care	that	legal	judgments	had	failed	to
resolve.	The	NHS	Ombudsman	has	repeatedly	revisited	the	issue	of	continuing	care	and	drawn	attention	to	the
inconsistent	and	incorrect	determination	of	eligibility	for	CHC	in	individual	cases.	The	latest	report	from	the	NAO
indicates	that	many	of	the	familiar	and	long-standing	criticisms	of	CHC	eligibility	continue	to	hold	sway.
The	issues	around	CHC	are	complex	but	the	key	considerations	include	the	following:
It’s	a	lottery:	the	numbers	of	people	eligible	for	CHC	vary	widely	from	28	to	356	people	per	50,000
population.	This	variation	cannot	be	explained	by	demographic	factors	and	“suggests	that	there	may	be
differences	in	the	way	CCGs	and	local	authorities	are	interpreting	the	national	framework.”
A	lot	of	people	are	assessed	for	CHC	but	relatively	few	are	deemed	eligible.	NHS	England	estimates	that
18%	of	initial	screenings	and	29%	of	people	referred	for	full	assessment	are	assessed	as	eligible	for	CHC.
Other	than	the	existence	of	a	national	framework	there	are	few	processes	for	ensuring	consistency	of
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eligibility	decision-making	either	within	or	between	CCGs.
Delays	in	completing	assessments	and	determinations	of	eligibility	are	common.	The	national	framework
states	that	eligibility	should	normally	be	determined	within	28	days,	but	the	NAO	reports	that	about	one	third
of	full	assessments	took	longer	to	complete	in	2015-16	(with	10%	of	CCGs	indicating	that	assessments	took
longer	than	100	days).	The	knock-on	effects	of	these	timescales	to	delayed	discharges	(transfers	of	care)
are	obvious.
The	outcome	of	an	assessment	has	major	cost	implications	for	patients	and	their	families,	local	authorities,
and	clinical	commissioning	groups	(CCGs).	For	people	who	are	not	deemed	eligible,	the	costs	of	care	will
be	transferred	mainly	to	the	social	care	system,	and	for	people	assessed	as	needing	to	pay	some	or	all	of
those	costs,	these	lie	where	they	fall.
Despite	large	numbers	of	people	failing	to	meet	eligibility	criteria,	CCGs	face	significant	costs	as	they	are
legally	obliged	to	pay	the	full	costs	of	those	who	are	eligible	(estimated	at	4%	of	all	CCG	expenditure).
Nonetheless,	CCGs	are	being	required	by	NHS	England	to	make	£855	million	in	savings	on	CHC	and	NHS-
funded	nursing	care	by	2020-21.
It	is	not	known	how	many	people	appeal	against	unsuccessful	CHC	funding	decisions.	Although	there	are
mechanisms	for	appeal,	there	is	no	central	data	collected	on	how	these	are	used.		It	is	known	that	cases
that	are	reviewed	can	lead	to	different	decisions.	In	2003/04	the	lack	of	consistency	of	eligibility	decisions
between	Strategic	Health	Authorities	(prior	to	national	eligibility	being	introduced)	led	to	a	requirement	for
review	and	widespread	restitution	which	refunded	the	costs	of	care	when	incorrect	eligibility	decisions	had
been	made.
Eligibility	for	CHC	is	not	about	diagnosis	(it	does	not,	for	example,	cover	everyone	with	dementia,	or	everyone
with	MS	or	Parkinson’s).	It	is	about	someone’s	specific	needs	for	healthcare,	and	particularly	involves	clinical
judgements	about	the	nature,	intensity,	complexity,	and	unpredictability	of	need.	All	of	these	dimensions	are
difficult	to	assess,	complex	to	understand,	and	inevitably	contain	a	highly	subjective	component.	In	any	nursing
home,	people	who	are	paying	for	their	own	care,	who	are	funded	through	the	local	authority,	or	who	are	fully
funded	by	the	NHS,	are	often	indistinguishable	from	one	another	in	any	common	sense	or	lay	understanding.	It	is
little	wonder	that	CHC	is	seen	as	unfair,	arbitrary,	and	illogical	–	particularly	by	those	people	and	their	families
who	cannot	understand	why	they	do	not	fit	eligibility	criteria.
A	great	amount	of	resources	and	staff	time	are	committed	to	undertaking	assessments	for	CHC,	and	–	in	effect	–
policing	the	boundary	between	care	and	health.	Given	the	significance	of	eligibility	decisions,	it	is	important	that
the	question	of	eligibility	is	considered	wherever	relevant.	The	fact	that	large	numbers	of	assessments	are
undertaken	and	find	people	ineligible	is	not	necessarily	an	argument	for	fewer	assessments,	but	for	critical
appraisal	of	why	so	few	make	it	through	the	assessment,	and	why	this	is	subject	to	so	much	variation.	When
patients	are	being	considered	for	discharge	from	hospital,	the	first	question	in	the	discharge	process	is	supposed
to	ask	whether	the	person	has	been	considered	for	CHC	eligibility.		This	is	an	important	check	and	safeguard	that
was	intended	to	ensure	that	people’s	needs	were	properly	assessed	before	major	decisions	about	their	care	were
made.
The	NAO	findings	add	to	evidence	built	up	over	the	last	two	decades	and	point	once	again	to	the	anomalous,
irregular,	inconsistent,	and	often	baffling	operation	of	CHC	eligibility	determination,	which	is	reflective	of	the	wider
fault	line	between	two	separate	but	parallel	systems	of	eligibility	and	funding	for	health	and	care,	and	cannot	be
resolved	in	isolation	from	it.	Any	debate	about	the	funding	of	long-term	care,	including	the	forthcoming	promised
Green	Paper,	will	need	to	address	this	central	dichotomy.
_______
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